Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2021

EA21 Newsletter: Session COVS1 Covid-19 induced respiratory failure

Saturday December 18, 08:15 – 09:15 – Channel 3

This three-part session on the complicated pathogenesis of Covid-19 induced respiratory failure will be opened by Professor Paolo Pelosi, Anesthesia and Critical Care – San Martino Policlinico Hospital – IRCCS for Oncology and Neurosciences – Genoa and Department of Surgical Sciences and Integrated Diagnostics – University of Genoa – Italy.

He will explain severe COVID-19 pneumonia shares several features with non-COVID-19 pulmonary acute respiratory distress syndrome (ARDS) since both are characterised by inflammatory lung injury, parenchymal stiffening and consolidation, alveolar and airway collapse and closure, altered vascular permeability, and diffuse alveolar damage (DAD).

Non-invasive respiratory support (NIRS) represents a possible first step in the management of COVID-19 patients, and the timing of intubation in COVID-19 seems not to influence clinical outcomes. Early intubation can be considered in patients with COVID-19 phenotype 2 (or H) who are at higher risk of disease progression,

He will conclude that COVID-19 pneumonia is characterised by a progressive increase in lung weight due to pneumolysis and vascular lysis affecting gas exchange. In early phases, low V/Q areas are predominant with good response to higher oxygen fraction and moderate levels of PEEP, while in the later stage true shunt is predominant with poor response to higher oxygen fractions and PEEP. Oxygenation worsening during non-invasive respiratory support requires early intubation and invasive mechanical ventilation.

In the presentation “Mechanical Ventilation in COVID-19”, Dr Juliana Ferreira (Hospital das Clínicas and Faculty of Medicine, University of Sao Paulo, Brazil) will address the indication for ventilatory support in acute respiratory failure in COVID-19, summarise the reported use and outcomes of mechanical ventilation in COVID-19 in the literature, and review current recommendations for ventilatory support in COVID-19.

She says “I will present the results of large epidemiological studies estimating the need for mechanical ventilation to be between 30-90%, depending on the population included. In the UK, it has also been found that non-survivors were disproportionally non-white and from more deprived areas, underscoring that health inequities play a role in critical COVID-19  outcomes. Studies including critically ill patients reported the use of moderate-to-high PEEP, high FIO2, and good adherence to protective ventilation (tidal volumes 4-8mL/Kg of predicted body weight and plateau pressures below 30 cmH2O).”

She concludes: “Importantly, protective ventilation was associated with increased survival in a large cohort of critical patients in Brazil. Current recommendations include the use of protective ventilation, a trial of higher PEEP tailored to individual response, and prone positioning for 12-16 hours for patients with PF ratios <150.”

The third talk in this session on “Non-invasive respiratory support and patient self-inflicted lung injury in Covid-19” will be given by Professor Christian Putensen, University Hospital Bonn, Germany.

Read More of our special newsletter covering our virtual congress